Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Clinical trial NCT02847598 · COMPLETED
Trial details
- NCT number
- NCT02847598
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-20
- Primary completion
- 2019-08-28
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.